Microbes and Cancer: Friends or Faux?

被引:66
作者
Azevedo, Maria Manuel [1 ,2 ,3 ]
Pina-Vaz, Cidalia [1 ,2 ]
Baltazar, Fatima [4 ,5 ,6 ]
机构
[1] Univ Porto, Fac Med, Dept Microbiol, P-4200319 Porto, Portugal
[2] Univ Porto, Fac Med, CINTESIS, P-4200319 Porto, Portugal
[3] Agrp Escolas D Maria II, P-4760067 V N Famalicao, Portugal
[4] Univ Minho, Sch Med, Life & Hlth Sci Res Inst ICVS, Campus Gualtar, P-4710057 Braga, Portugal
[5] ICVS 3Bs PT Govt Associate Lab, P-4710057 Braga, Portugal
[6] ICVS 3Bs PT Govt Associate Lab, P-4835258 Guimaraes, Portugal
关键词
cancer; infection; microbiome; cancer dysbiosis; tumor microbiome; cancer therapy response; EPSTEIN-BARR-VIRUS; INVASIVE FUNGAL-INFECTIONS; NON-HODGKINS-LYMPHOMA; PANCREATIC-CANCER; HELICOBACTER-PYLORI; GUT MICROBIOTA; GASTRIC-CANCER; TRANSPLANT RECIPIENTS; COLORECTAL-CANCER; CURRENT KNOWLEDGE;
D O I
10.3390/ijms21093115
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cancer is one of the most aggressive and deadly diseases in the world, representing the second leading cause of death. It is a multifactorial disease, in which genetic alterations play a key role, but several environmental factors also contribute to its development and progression. Infections induced by certain viruses, bacteria, fungi and parasites constitute risk factors for cancer, being chronic infection associated to the development of certain types of cancer. On the other hand, susceptibility to infectious diseases is higher in cancer patients. The state of the host immune system plays a crucial role in the susceptibility to both infection and cancer. Importantly, immunosuppressive cancer treatments increase the risk of infection, by decreasing the host defenses. Furthermore, alterations in the host microbiota is also a key factor in the susceptibility to develop cancer. More recently, the identification of a tumor microbiota, in which bacteria establish a symbiotic relationship with cancer cells, opened a new area of research. There is evidence demonstrating that the interaction between bacteria and cancer cells can modulate the anticancer drug response and toxicity. The present review focuses on the interaction between microbes and cancer, specifically aiming to: (1) review the main infectious agents associated with development of cancer and the role of microbiota in cancer susceptibility; (2) highlight the higher vulnerability of cancer patients to acquire infectious diseases; (3) document the relationship between cancer cells and tissue microbiota; (4) describe the role of intratumoral bacteria in the response and toxicity to cancer therapy.
引用
收藏
页数:23
相关论文
共 189 条
  • [31] Bone Marrow Dendritic Cells from Mice with an Altered Microbiota Provide Interleukin 17A-Dependent Protection against Entamoeba histolytica Colitis
    Burgess, Stacey L.
    Buonomo, Erica
    Carey, Maureen
    Cowardin, Carrie
    Naylor, Caitlin
    Noor, Zannatun
    Wills-Karp, Marsha
    Petri, William A., Jr.
    [J]. MBIO, 2014, 5 (06):
  • [32] Pathogenesis of Helicobacter pylori infection
    Camilo, Vania
    Sugiyama, Toshiro
    Touati, Eliette
    [J]. HELICOBACTER, 2017, 22
  • [33] HIV-associated Hodgkin lymphoma
    Carbone, Antonino
    Gloghini, Annunziata
    Serraino, Diego
    Spina, Michele
    [J]. CURRENT OPINION IN HIV AND AIDS, 2009, 4 (01) : 3 - 10
  • [34] Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma
    Castellarin, Mauro
    Warren, Rene L.
    Freeman, J. Douglas
    Dreolini, Lisa
    Krzywinski, Martin
    Strauss, Jaclyn
    Barnes, Rebecca
    Watson, Peter
    Allen-Vercoe, Emma
    Moore, Richard A.
    Holt, Robert A.
    [J]. GENOME RESEARCH, 2012, 22 (02) : 299 - 306
  • [35] Chang XB, 2010, METHODS MOL BIOL, V596, P223, DOI 10.1007/978-1-60761-416-6_11
  • [36] Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab
    Chaput, N.
    Lepage, P.
    Coutzac, C.
    Soularue, E.
    Le Roux, K.
    Monot, C.
    Boselli, L.
    Routier, E.
    Cassard, L.
    Collins, M.
    Vaysse, T.
    Marthey, L.
    Eggermont, A.
    Asvatourian, V.
    Lanoy, E.
    Mateus, C.
    Robert, C.
    Carbonnel, F.
    [J]. ANNALS OF ONCOLOGY, 2017, 28 (06) : 1368 - 1379
  • [37] Human Intestinal Lumen and Mucosa-Associated Microbiota in Patients with Colorectal Cancer
    Chen, Weiguang
    Liu, Fanlong
    Ling, Zongxin
    Tong, Xiaojuan
    Xiang, Charlie
    [J]. PLOS ONE, 2012, 7 (06):
  • [38] Tissue Microbiome Profiling Identifies an Enrichment of Specific Enteric Bacteria in Opisthorchis viverrini Associated Cholangiocarcinoma
    Chng, Kern Rei
    Chan, Sock Hoai
    Ng, Amanda Hui Qi
    Li, Chenhao
    Jusakul, Apinya
    Bertrand, Denis
    Wilm, Andreas
    Choo, Su Pin
    Tan, Damien Meng Yew
    Lim, Kiat Hon
    Soetinko, Roy
    Ong, Choon Kiat
    Duda, Dan G.
    Dima, Simona
    Popescu, Irinel
    Wongkham, Chaisiri
    Feng, Zhu
    Yeoh, Khay Guan
    Teh, Bin Tean
    Yongvanit, Puangrat
    Wongkham, Sopit
    Bhudhisawasd, Vajaraphongsa
    Khuntikeo, Narong
    Tan, Patrick
    Pairojkul, Chawalit
    Ngeow, Joanne
    Nagarajan, Niranjan
    [J]. EBIOMEDICINE, 2016, 8 : 195 - 202
  • [39] The Impact of the Gut Microbiota on Human Health: An Integrative View
    Clemente, Jose C.
    Ursell, Luke K.
    Parfrey, Laura Wegener
    Knight, Rob
    [J]. CELL, 2012, 148 (06) : 1258 - 1270
  • [40] Faecal microbiota transplantation protects against radiation-induced toxicity
    Cui, Ming
    Xiao, Huiwen
    Li, Yuan
    Zhou, Lixin
    Zhao, Shuyi
    Luo, Dan
    Zheng, Qisheng
    Dong, Jiali
    Zhao, Yu
    Zhang, Xin
    Zhang, Junling
    Lu, Lu
    Wang, Haichao
    Fan, Saijun
    [J]. EMBO MOLECULAR MEDICINE, 2017, 9 (04) : 448 - 461